The "Sputnik V" vaccine demonstrated an over 90 percent effectiveness in people over 60 years old
26 December 2020
"The Russian Ministry of Health approved the use of the vaccine for people over 60 years of age after clinical trials that have shown complete safety and efficacy over 90% in this age group," the vaccine manufacturer said on Twitter.
Text: Ksania Pan'kova
Photo: Frank Augstein/АР/ТАСС
www.vz.ru